SCHEMBL9963575

SCHEMBL9963575

Cc1c2nc(NCC(=O)NC3CCC(N4CCCC4)CC3)sc2cc2sc(NCC(=O)N3CCCC3)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
PTGS2 P35354 2/20 0.39
ACHE P22303 2/20 0.37
BCHE P06276 1/20 0.37
GRIN2B Q13224 1/20 0.37
PDE7A Q13946 10/20 0.37
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
G6PD P11413 1/20 0.35
HPGD P15428 1/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
HSD17B10 Q99714 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LIPG Q9Y5X9 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
CCRL2 O00421 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963564 0.91 PTGS2 (0.43) PTGS2KDM4EALDH1A1MAPTHPGD
SCHEMBL9963661 0.90 LIPG (0.35) TP53PTGS2ACHEBCHEGRIN2B
SCHEMBL9963572 0.89 TP53 (0.51) TP53PTGS2ACHEBCHEGRIN2B
SCHEMBL9963585 0.86 BCHE (0.45) TP53PTGS2ACHEBCHEGRIN2B
SCHEMBL9963580 0.85 ACHE (0.45) TP53PTGS2ACHEBCHEGRIN2B
SCHEMBL9963549 0.84 ACHE (0.46) TP53PTGS2ACHEBCHEGRIN2B
SCHEMBL9963579 0.83 PTGS2 (0.38) TP53PTGS2KDM4EALDH1A1HPGD
SCHEMBL9963573 0.82 PTGS2 (0.39) TP53PTGS2ACHEBCHEGRIN2B
SCHEMBL9963481 0.81 ACHE (0.41) TP53PTGS2ACHEBCHEGRIN2B
SCHEMBL9963550 0.81 ACHE (0.42) TP53PTGS2ACHEBCHEGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 TP53 107/4885PTGS2 2872/4885ACHE 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.